Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamara Berno

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Clinical Lymphoma, Myeloma & Leukemia|July 5, 2015
Cytogenetic Impact on Lenalidomide Treatment in Relapsed/Refractory Multiple Myeloma: A Real-Life EvaluationRenato Zambello, Laura Bonaldi, Tamara Berno, et al.
Cancers|September 9, 2022
CK1α/RUNX2 Axis in the Bone Marrow Microenvironment: A Novel Therapeutic Target in Multiple MyelomaAnna Fregnani, Lara Saggin, Ketty Gianesin, et al.
Annals of Hematology|December 13, 2018
Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRIRenato Zambello, Filippo Crimì, Albana Lico, et al.
Cancer Reports (Hoboken, N.J.)|April 25, 2024
When Waldenström macroglobulinemia hits the kidney: Description of a case series and management of a "rare in rare" scenarioNicolò Danesin, Greta Scapinello, Dorella Del Prete, et al.
Frontiers in Oncology|July 2, 2021
Treatment Induced Cytotoxic T-Cell Modulation in Multiple Myeloma PatientsGregorio Barilà, Laura Pavan, Susanna Vedovato, et al.
Journal of the Peripheral Nervous System : JPNS|January 24, 2026
Pachymeningeal Involvement in POEMS Syndrome: Longitudinal Follow-Up Study and Correlation With Therapeutic ResponseChiara Briani, Luca Massarotti, Antonio Branca, et al.
European Journal of Haematology|April 12, 2011
Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patientsMaurizio Zangari, Monette Aujay, Fenghuang Zhan, et al.
Oncotarget|October 6, 2017
<i>STAT3</i> mutation impacts biological and clinical features of T-LGL leukemiaAntonella Teramo, Gregorio Barilà, Giulia Calabretto, et al.
International Journal of Cardiology|July 22, 2023
Chest pain in cardiac amyloidosis: occurrence, causes and prognostic significanceLaura De Michieli, Monica De Gaspari, Giulio Sinigiani, et al.
Frontiers in Oncology|July 10, 2023
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignanciesFrancesco Angotzi, Marco Petrella, Tamara Berno, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Clinical Lymphoma, Myeloma & Leukemia|July 5, 2015
Cytogenetic Impact on Lenalidomide Treatment in Relapsed/Refractory Multiple Myeloma: A Real-Life EvaluationRenato Zambello, Laura Bonaldi, Tamara Berno, et al.
Cancers|September 9, 2022
CK1α/RUNX2 Axis in the Bone Marrow Microenvironment: A Novel Therapeutic Target in Multiple MyelomaAnna Fregnani, Lara Saggin, Ketty Gianesin, et al.
Annals of Hematology|December 13, 2018
Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRIRenato Zambello, Filippo Crimì, Albana Lico, et al.
Cancer Reports (Hoboken, N.J.)|April 25, 2024
When Waldenström macroglobulinemia hits the kidney: Description of a case series and management of a "rare in rare" scenarioNicolò Danesin, Greta Scapinello, Dorella Del Prete, et al.
Frontiers in Oncology|July 2, 2021
Treatment Induced Cytotoxic T-Cell Modulation in Multiple Myeloma PatientsGregorio Barilà, Laura Pavan, Susanna Vedovato, et al.
Journal of the Peripheral Nervous System : JPNS|January 24, 2026
Pachymeningeal Involvement in POEMS Syndrome: Longitudinal Follow-Up Study and Correlation With Therapeutic ResponseChiara Briani, Luca Massarotti, Antonio Branca, et al.
European Journal of Haematology|April 12, 2011
Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patientsMaurizio Zangari, Monette Aujay, Fenghuang Zhan, et al.
Oncotarget|October 6, 2017
<i>STAT3</i> mutation impacts biological and clinical features of T-LGL leukemiaAntonella Teramo, Gregorio Barilà, Giulia Calabretto, et al.
International Journal of Cardiology|July 22, 2023
Chest pain in cardiac amyloidosis: occurrence, causes and prognostic significanceLaura De Michieli, Monica De Gaspari, Giulio Sinigiani, et al.
Frontiers in Oncology|July 10, 2023
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignanciesFrancesco Angotzi, Marco Petrella, Tamara Berno, et al.
Pageof 3